CVRx Ownership | Who Owns CVRx?
CVRx Ownership Summary
CVRx is owned by 45.71% institutional investors, 4.28% insiders, and 50.01% retail investors. Johnson & johnson is the largest institutional shareholder, holding 15.38% of CVRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.60% of its assets in CVRx shares.
CVRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | CVRx | 45.71% | 4.28% | 50.01% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Medical Device Stocks | 37.54% | 10.61% | 51.85% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Johnson & johnson | 4.02M | 15.38% | $28.58M |
| Nea management company | 2.03M | 7.77% | $16.35M |
| Vanguard group | 1.12M | 4.28% | $7.96M |
| Blackrock | 875.75K | 4.12% | $10.50M |
| Blackrock funding, inc. /de | 1.06M | 4.05% | $7.53M |
| Gsk | 1.01M | 3.85% | $7.15M |
| Balyasny asset management | 674.68K | 2.59% | $3.97M |
| Parkman healthcare partners | 491.41K | 1.88% | $3.97M |
| Millennium management | 405.00K | 1.78% | $5.13M |
| Geode capital management | 403.95K | 1.54% | $2.87M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Johnson & johnson | 4.02M | 5.15% | $28.58M |
| Fourworld capital management | 145.00K | 1.85% | $1.17M |
| Nea management company | 2.03M | 0.90% | $16.35M |
| Gsk | 1.01M | 0.90% | $7.15M |
| Parkman healthcare partners | 491.41K | 0.41% | $3.97M |
| Corton capital | 10.59K | 0.21% | $85.46K |
| Stoneridge investment partners | 23.65K | 0.12% | $168.00K |
| Gsa capital partners llp | 183.53K | 0.11% | $1.30M |
| Perkins capital management | 16.15K | 0.09% | $114.67K |
| Wexford capital lp | 46.06K | 0.05% | $371.70K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Gsk | 1.01M | 0.90% | 1.01M |
| Balyasny asset management | 674.68K | 0.01% | 267.06K |
| Jane street group | 225.35K | 0.00% | 153.84K |
| Norges bank | 111.40K | 0.00% | 111.40K |
| Blackrock | 875.75K | 0.00% | 110.75K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Emerald advisers | - | - | -590.85K |
| Soleus capital management | - | - | -587.10K |
| Lord, abbett | - | - | -396.76K |
| Emerald mutual fund advisers trust | - | - | -369.67K |
| Marshall wace, llp | 16.15K | 0.00% | -333.93K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Gsk | 1.01M | 0.90% | 1.01M | $7.15M |
| Norges bank | 111.40K | 0.00% | 111.40K | $1.41M |
| Wexford capital lp | 46.06K | 0.05% | 46.06K | $371.70K |
| Graham capital management | 21.84K | 0.00% | 21.84K | $176.26K |
| R squared | 10.43K | 0.03% | 10.43K | $74.05K |
Sold Out
| Holder | Change |
|---|---|
| Caitong asset management | -2.00 |
| Capital performance advisors llp | -2.00 |
| Farther finance advisors | -3.00 |
| True wealth design | -3.00 |
| Rothschild investment | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 68 | -27.66% | 11,961,416 | -14.58% | 45 | 1.58% | 28 | -39.13% | 27 | 3.85% |
| Sep 30, 2025 | 92 | 8.24% | 14,003,437 | -0.09% | 53 | 1.86% | 45 | -15.09% | 26 | 73.33% |
| Jun 30, 2025 | 92 | -7.07% | 14,539,988 | -8.96% | 55 | 1.46% | 55 | 5.77% | 17 | -26.09% |
| Mar 31, 2025 | 98 | 3.16% | 16,179,554 | 6.77% | 62 | 1.41% | 52 | 15.56% | 23 | -23.33% |
| Dec 31, 2024 | 93 | 6.90% | 15,132,616 | 7.14% | 66 | 1.73% | 44 | -20.00% | 30 | 87.50% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 684.12K | 2.60% | - |
| iShares Russell 2000 ETF | 380.85K | 1.45% | 380.85K |
| JPMorgan US Small Company L | 211.19K | 0.81% | -25.67K |
| Silvercrest U.S. Small Cap Growth | 187.11K | 0.71% | 81.26K |
| Vanguard Institutional Extnd Mkt Idx Tr | 185.82K | 0.71% | - |
| Fidelity Small Cap Index | 169.29K | 0.64% | -201.00 |
| Mairs & Power Small Cap | 142.46K | 0.54% | - |
| Mairs & Power Small Cap Composite | 142.46K | 0.54% | - |
| iShares Russell 2000 Growth ETF | 140.85K | 0.54% | 59.06K |
| CREF Stock R1 | 116.11K | 0.46% | -51.73K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 02, 2026 | Adamson Philip B. | Chief Medical Officer | Sell | $9.97K |
| Mar 02, 2026 | Hykes Kevin | PRES & CEO | Sell | $61.35K |
| Mar 02, 2026 | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | $10.15K |
| Mar 02, 2026 | OASHEIM JARED | CHIEF FINANCIAL OFFICER | Sell | $13.78K |
| Mar 02, 2026 | John Robert Allen | Chief Revenue Officer | Sell | $31.33K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | 2 | 4 |
| 2025 Q4 | - | 8 |
| 2025 Q3 | - | - |
| 2025 Q2 | 7 | - |
| 2025 Q1 | - | - |
CVRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools